(Q34316288)

English

Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity

scientific article

Statements

Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity (English)
Melinda Hollingshead
Joseph Tomaszewski
National Cancer Institute Phase 0 Clinical Trials Team

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit